**Core Concept**
The BRCA2 gene is a tumor suppressor gene that plays a crucial role in the repair of DNA damage. Mutations in the BRCA2 gene increase the risk of developing certain types of cancer, particularly breast, ovarian, and prostate cancer. The BRCA2 gene is involved in the homologous recombination repair pathway, which is essential for maintaining genomic stability.

**Why the Correct Answer is Right**
The correct answer is associated with the type of cancer not typically linked to BRCA2 mutations. BRCA2 mutations are primarily associated with breast, ovarian, and prostate cancer. This is because BRCA2 is involved in the repair of DNA double-strand breaks, and mutations in this gene impair the cell's ability to repair DNA damage, leading to genetic instability and increased cancer risk.

**Why Each Wrong Option is Incorrect**
**Option A:** Breast cancer is actually associated with BRCA2 mutations, making it an incorrect answer.
**Option B:** Ovarian cancer is also linked to BRCA2 mutations, so this option is incorrect as well.
**Option C:** Prostate cancer is commonly associated with BRCA2 mutations, especially in men with a family history of breast cancer. Therefore, this option is incorrect.

**Clinical Pearl / High-Yield Fact**
A key clinical correlation is that BRCA2 mutations are associated with an increased risk of pancreatic cancer, particularly in men. This is an important consideration in the management of patients with a family history of breast, ovarian, or prostate cancer.

**Correct Answer:** D.